The in vivo antinociceptive and μ-opioid receptor activating effects of the combination of N-phenyl-2′,4′-dimethyl-4,5′-bi-1,3-thiazol-2-amines and naloxone-Reference-Cited by-同舟云学术

The in vivo antinociceptive and μ-opioid receptor activating effects of the combination of N-phenyl-2′,4′-dimethyl-4,5′-bi-1,3-thiazol-2-amines and naloxone

Published:2019-04 Issue: Volume:167 Page:312-323
ISSN:0223-5234
Container-title:European Journal of Medicinal Chemistry
language:en
Short-container-title:European Journal of Medicinal Chemistry

Author:

Lin Shu-Yu,Kuo Yu-Hsien,Tien Ya-Wen,Ke Yi-Yu,Chang Wan-Ting,Chang Hsiao-Fu,Ou Li-Chin,Law Ping-Yee,Xi Jing-Hua,Tao Pao-Luh,Loh Horace H.,Chao Yu-Sheng,Shih Chuan,Chen Chiung-Tong,Yeh Shiu-Hwa,Ueng Shau-Hua^ORCID

Funder

Ministry of Science and Technology

Intramural Research Program of the National Health Research Institutes

Publisher

Elsevier BV

Subject

Organic Chemistry,Drug Discovery,Pharmacology,General Medicine

Reference41 articles.

1. History of opium;Aragon-Poce;Int. Congr.,2002

2. History of spine surgery in the ancient and medieval worlds;Goodrich;Neurosurg. Focus,2004

3. College on problems of drug dependence taskforce on prescription opioid non-medical use and abuse: Position statement;Zacny;Drug Alcohol Depend.,2003

4. Major increases in opioid analgesic abuse in the United States: Concerns and strategies;Compton;Drug Alcohol Depend.,2006

5. A reassessment of trends in the medical use and abuse of opioid analgesics and implications for diversion control: 1997–2002;Gilson;J. Pain Symptom Manag.,2004

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Discovery of a mu-opioid receptor modulator that in combination with morphinan antagonists induces analgesia;Cell Chemical Biology;2024-07

2. Structure-Based Drug Design and Synthesis of Novel N-Aryl-2,4-bithiazole-2-amine CYP1B1-Selective Inhibitors in Overcoming Taxol Resistance in A549 Cells;Journal of Medicinal Chemistry;2022-12-13

3. Selective and antagonist-dependent µ-opioid receptor activation by the combination of 2-{[2-(6-chloro-3,4-dihydro-1(2H)-quinolinyl)-2-oxoethyl]sulfanyl}-5-phenyl-4,6-(1H,5H)-pyrimidinedione and naloxone/naltrexone;Bioorganic Chemistry;2022-11

4. Thiazole derivatives in medicinal chemistry: Recent advancements in synthetic strategies, structure activity relationship and pharmacological outcomes;Journal of Molecular Structure;2022-10

5. In vitro functional assays as a tool to study new synthetic opioids at the μ-opioid receptor: Potential, pitfalls and progress;Pharmacology & Therapeutics;2022-07